Q1 2024 · 13F-HR
BAIN CAPITAL INVESTORS LLCholdings as filed
Filed 2024-05-15 · accession 0000950123-24-005302
$4.48B
Reported value
4
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $2.78B | 61.9% | 65,679,781 | Common | SOLE |
| 86881A100 | SGRY | SURGERY PARTNERS INC | $1.49B | 33.2% | 49,946,972 | Common | SOLE |
| 05356F105 | AVAH | AVEANNA HEALTHCARE HLDGS INC | $203.2M | 4.53% | 81,600,880 | Common | SOLE |
| 00791N102 | — | ADVANTAGE SOLUTIONS INC | $12.5M | 0.28% | 2,890,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.